000			02182 a2200553 4500
005			20250513083832.0
264		0	_c19960214
008			199602s 0 0 eng d
022			_a0022-1767
040			_aNLM _beng _cNLM
100	1		_aWingett, D
245	0	0	_apim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cJan 1996
300			_a549-57 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aCalcium _xphysiology
650	0	4	_aCell Nucleus _xmetabolism
650	0	4	_aCytoplasm _xmetabolism
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aEnzyme Induction _xphysiology
650	0	4	_aHumans
650	0	4	_aIonomycin _xpharmacology
650	0	4	_aIsoenzymes _xmetabolism
650	0	4	_aLeukemia-Lymphoma, Adult T-Cell _xpathology
650	0	4	_aLymphocyte Activation _xphysiology
650	0	4	_aMuromonab-CD3 _xpharmacology
650	0	4	_aProtein Kinase C _xmetabolism
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aProto-Oncogene Mas
650	0	4	_aProto-Oncogene Proteins _xbiosynthesis
650	0	4	_aProto-Oncogene Proteins c-pim-1
650	0	4	_aProto-Oncogene Proteins c-raf
650	0	4	_aProto-Oncogenes
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aReceptor-CD3 Complex, Antigen, T-Cell _xantagonists & inhibitors
650	0	4	_aReceptors, Antigen, T-Cell _ximmunology
650	0	4	_aSezary Syndrome _xpathology
650	0	4	_aSignal Transduction _xphysiology
650	0	4	_aSkin Neoplasms _xpathology
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aTetradecanoylphorbol Acetate _xpharmacology
650	0	4	_aTranscription, Genetic
650	0	4	_aTransfection
650	0	4	_aTumor Cells, Cultured
700	1		_aLong, A
700	1		_aKelleher, D
700	1		_aMagnuson, N S
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 156 _gno. 2 _gp. 549-57
999			_c8542904 _d8542904